Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 34, 2009, Pages 14287-14292

  Daniel, Andrea R ^a   Lange, Carol A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

HDAC; Phosphorylation; Sumoylation

Indexed keywords

AGAR; ANTIGESTAGEN; GESTAGEN; GROWTH FACTOR; MIFEPRISTONE; PROGESTERONE RECEPTOR; PROMEGESTONE; PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER THERAPY; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN T47D; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CULTURE MEDIUM; EXPERIMENTAL MODEL; FEMALE; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SUMOYLATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HELA CELLS; HUMANS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR I; LIGANDS; MUTATION; PHOSPHORYLATION; PROGESTINS; PROMOTER REGIONS, GENETIC; PROTEIN KINASES; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION, GENETIC;

EID: 70149092341     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0905118106     Document Type: Article

References (37)

1. Brisken C, et al. (1998) A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA 95:5076-5081. (Pubitemid 28208553)
2. Conneely OM, Jericevic BM, Lydon JP (2003) Progesterone receptors in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 8:205-214. (Pubitemid 38129942)
3. Qiu M, Lange CA (2003) MAP kinases couple multiple functions of human progesterone receptors: Degradation, transcriptional synergy, and nuclear association. J Steroid Biochem Mol Biol 85:147-157. (Pubitemid 37020885)
4. Faivre EJ, Lange CA (2007) Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivationandc-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells. Mol Cell Biol 27:466-480.
5. Daniel AR, Faivre EJ, Lange CA (2007) Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells. Mol Endocrinol 21:2890-2906.
6. Holmstrom S, Van Antwerp ME, Iniguez-Lluhi JA (2003) Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc Natl Acad Sci USA 100:15758-15763. (Pubitemid 38021063)
7. Jacobsen BM, Schittone SA, Richer JK, Horwitz KB (2005) Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. Mol Endocrinol 19:574-587.
8. Richer JK, et al. (2002) Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277:5209-5218. (Pubitemid 34968565)
9. Abdel-Hafiz H, Takimoto GS, Tung L, Horwitz KB (2002) The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. J Biol Chem 277:33950-33956. (Pubitemid 35056210)
10. Lange CA, Shen T, Horwitz KB (2000) Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome. Proc Natl Acad Sci USA 97:1032-1037. (Pubitemid 30080807)
11. Groshong SD, et al. (1997) Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 11:1593-1607.
12. Chang AC, Jellinek DA, Reddel RR (2003) Mammalian stanniocalcins and cancer. Endocr Relat Cancer 10:359-373.
13. Qiu M, Olsen A, Faivre E, Horwitz KB, Lange CA (2003) Mitogen-activated protein kinase regulates nuclear association of human progesterone receptors. Mol Endocrinol 17:628-642. (Pubitemid 36403575)
14. Shen T, Horwitz KB, Lange CA (2001) Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol Cell Biol 21:6122-6131. (Pubitemid 34263512)
15. Krek W, Nigg EA (1991) Mutations of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: Evidence for a double block to p34cdc2 kinase activation in vertebrates. EMBO J 10:3331-3341. (Pubitemid 21905358)
16. Lopez-Beltran A, MacLennan GT, Montironi R (2006) Cyclin E as molecular marker in the management of breast cancer: A review. Anal Quant Cytol Histol 28:111-114.
17. Byron SA, et al. (2006) Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. Br J Cancer 95:1220-1228.
18. Daniel AR, et al. (2007) Linkage of progestin and epidermal growth factor signaling: Phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72:188-201.
19. Bouras T, et al. (2002) Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62:1289-1295. (Pubitemid 34407780)
20. Charpentier AH, et al. (2000) Effects of estrogen on global gene expression: Identification of novel targets of estrogen action. Cancer Res 60:5977-5983.
21. Lange CA, et al. (2008) Progesterone receptor action: Translating studies in breast cancer models to clinical insights. Adv Exp Med Biol 630:94-111.
22. Yang SH, Sharrocks AD (2004) SUMO promotes HDAC-mediated transcriptional repression. Mol Cell 13:611-617. (Pubitemid 38299387)
23. Arito M, Horiba T, Hachimura S, Inoue J, Sato R (2008) Growth factor-induced phosphorylation of srebps inhibits sumoylation, thereby stimulating the expression of their target genes, LDL uptake and lipid synthesis. J Biol Chem 283:15224-15231.
24. Man JH, et al. (2006) PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus. Nucleic Acids Res 34:5552-5566.
25. Boonyaratanakornkit V, et al. (2008) The role and mechanims of progesterone receptor crosstalk with signal transduction pathways. Keystone Symposia on Molecular Cell Biology, Nuclear Receptors: Orphan Brothers and Steroid Sisters (Keystone Symposia, Silverthorne, CO), p 109.
26. So AY, Cooper SB, Feldman BJ, Manuchehri M, Yamamoto KR (2008) Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes. Proc Natl Acad Sci USA 105:5745-5749. (Pubitemid 351758443)
27. Hall JM, McDonnell DP, Korach KS (2002) Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol Endocrinol 16:469-486.
28. Chu I, et al. (2007) Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer. J Clin Invest 117:2205-2215. (Pubitemid 47219565)
29. Mote PA, Bartow S, Tran N, Clarke CL (2002) Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis. Breast Cancer Res Treat 72:163-172. (Pubitemid 34407211)
30. Graham JD, et al. (1995) Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res 55:5063-5068.
31. Arpino G, et al. (2005) Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst 97:1254-1261. (Pubitemid 41535366)
32. Pierson-Mullany LK, Lange CA (2004) Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Mol Cell Biol 24:10542-10557.
33. Lange CA, Richer JK, Shen T, Horwitz KB (1998) Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways. J Biol Chem 273:31308-31316. (Pubitemid 28533147)
34. Sartorius CA, et al. (1994) New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: Only antiprogestin- occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54:3868-3877.
35. Sachdev D, et al. (2003) A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Cancer Res 63:627-635. (Pubitemid 36158140)
36. Ostrander JH, Daniel AR, Lofgren K, Kleer CG, Lange CA (2007) Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res 67:4199-4209. (Pubitemid 46815066)
37. Faivre EJ, Daniel AR, Hillard CJ, Lange CA (2008) Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors. Mol Endocrinol 22:823-837.